DaVita Inc V.DVA

Primary Symbol: DVA

Healthcare

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

NYSE:DVA - Post by User

DaVita Inc > Reasons for decline?

<< Previous

Bullboard Posts

Next >>

Comment by PlantManager013on Jul 31, 2017 1:11pm

46 Views

Post# 26529358

RE:RE:Reasons for decline?

Congrats! i think you got a good deal.

As far as ISOL goes, the pattern I have observed with similar stocks is - they het a bump up when WEED makes an agreement with them, or due to some other news, then they drift down.

I am in no rush to buy ISOL. I will wait for the drift down. I understand their products are not likely to be legal in the first stages of legalization anyway. That means, people will shift their attention to immediate returns and away from ISOL, as we get closer to Legalisation.

<< Previous

Bullboard Posts

Next >>

Tilray Brands launches Charlotte's Web CBD gummies in Canada